| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 6.87e-05 | 43 | 37 | 3 | GO:0030280 | |
| GeneOntologyBiologicalProcess | intermediate filament organization | 8.70e-06 | 75 | 36 | 4 | GO:0045109 | |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 2.61e-05 | 99 | 36 | 4 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 2.72e-05 | 100 | 36 | 4 | GO:0045103 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | 2.91e-05 | 957 | 36 | 9 | GO:0097435 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | 1.44e-04 | 899 | 37 | 8 | GO:0099513 | |
| GeneOntologyCellularComponent | supramolecular fiber | 1.66e-04 | 1179 | 37 | 9 | GO:0099512 | |
| GeneOntologyCellularComponent | supramolecular polymer | 1.75e-04 | 1187 | 37 | 9 | GO:0099081 | |
| GeneOntologyCellularComponent | keratin filament | 6.71e-04 | 97 | 37 | 3 | GO:0045095 | |
| GeneOntologyCellularComponent | intermediate filament | 6.75e-04 | 227 | 37 | 4 | GO:0005882 | |
| GeneOntologyCellularComponent | axon | 8.38e-04 | 891 | 37 | 7 | GO:0030424 | |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 1.17e-03 | 263 | 37 | 4 | GO:0045111 | |
| HumanPheno | Perifollicular hyperkeratosis | 1.76e-07 | 4 | 19 | 3 | HP:0007468 | |
| HumanPheno | Abnormal perifollicular morphology | 8.74e-07 | 6 | 19 | 3 | HP:0031285 | |
| HumanPheno | Variable expressivity | 1.05e-05 | 84 | 19 | 5 | HP:0003828 | |
| HumanPheno | Variable phenotype | 1.05e-05 | 84 | 19 | 5 | HP:0003813 | |
| HumanPheno | Diffuse spongiform leukoencephalopathy | 3.95e-05 | 3 | 19 | 2 | HP:0006943 | |
| HumanPheno | Patchy alopecia | 1.08e-04 | 26 | 19 | 3 | HP:0002232 | |
| HumanPheno | Abnormality of hair growth rate | 1.51e-04 | 29 | 19 | 3 | HP:0011363 | |
| HumanPheno | Slow-growing hair | 1.51e-04 | 29 | 19 | 3 | HP:0002217 | |
| HumanPheno | Follicular hyperkeratosis | 1.68e-04 | 30 | 19 | 3 | HP:0007502 | |
| HumanPheno | Abnormality of hair growth | 1.68e-04 | 30 | 19 | 3 | HP:0040170 | |
| HumanPheno | Keratosis pilaris | 3.16e-04 | 37 | 19 | 3 | HP:0032152 | |
| Domain | Intermediate_filament_CS | 6.38e-06 | 63 | 36 | 4 | IPR018039 | |
| Domain | Filament | 1.03e-05 | 71 | 36 | 4 | SM01391 | |
| Domain | IF | 1.09e-05 | 72 | 36 | 4 | PS00226 | |
| Domain | Filament | 1.15e-05 | 73 | 36 | 4 | PF00038 | |
| Domain | Keratin_2_head | 1.29e-05 | 24 | 36 | 3 | IPR032444 | |
| Domain | Keratin_2_head | 1.29e-05 | 24 | 36 | 3 | PF16208 | |
| Domain | IF | 1.35e-05 | 76 | 36 | 4 | IPR001664 | |
| Domain | Keratin_II | 1.66e-05 | 26 | 36 | 3 | IPR003054 | |
| Domain | Coatomer/clathrin_app_Ig-like | 2.36e-04 | 12 | 36 | 2 | IPR013041 | |
| Domain | Growth_fac_rcpt_ | 3.33e-03 | 156 | 36 | 3 | IPR009030 | |
| Domain | ARM-type_fold | 3.97e-03 | 339 | 36 | 4 | IPR016024 | |
| Domain | HEAT_REPEAT | 8.03e-03 | 70 | 36 | 2 | PS50077 | |
| Domain | ARM-like | 1.50e-02 | 270 | 36 | 3 | IPR011989 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 2.86e-05 | 87 | 29 | 4 | MM15351 | |
| Pathway | REACTOME_MIRO_GTPASE_CYCLE | 8.53e-05 | 7 | 29 | 2 | MM15689 | |
| Pathway | REACTOME_MIRO_GTPASE_CYCLE | 1.14e-04 | 8 | 29 | 2 | M41837 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 1.33e-04 | 129 | 29 | 4 | M27649 | |
| Pathway | REACTOME_KERATINIZATION | 2.56e-04 | 153 | 29 | 4 | MM15343 | |
| Pathway | REACTOME_KERATINIZATION | 9.59e-04 | 217 | 29 | 4 | M27640 | |
| Pathway | WP_EFFECTS_OF_MFN2_MUTATION | 1.10e-03 | 24 | 29 | 2 | M48308 | |
| Pubmed | Sequence data and chromosomal localization of human type I and type II hair keratin genes. | 1.11e-09 | 3 | 37 | 3 | 7556444 | |
| Pubmed | Structure and site of expression of a murine type II hair keratin. | 1.11e-09 | 3 | 37 | 3 | 1372089 | |
| Pubmed | 1.11e-09 | 3 | 37 | 3 | 1712823 | ||
| Pubmed | Novel KRT83 and KRT86 mutations associated with monilethrix. | 1.11e-09 | 3 | 37 | 3 | 25557232 | |
| Pubmed | 4.43e-09 | 4 | 37 | 3 | 15797458 | ||
| Pubmed | Characterization of a 300 kbp region of human DNA containing the type II hair keratin gene domain. | 2.42e-07 | 12 | 37 | 3 | 10692104 | |
| Pubmed | Comprehensive analysis of keratin gene clusters in humans and rodents. | 6.15e-07 | 16 | 37 | 3 | 15085952 | |
| Pubmed | 6.17e-07 | 63 | 37 | 4 | 16831889 | ||
| Pubmed | PERP regulates enamel formation via effects on cell-cell adhesion and gene expression. | 1.06e-06 | 19 | 37 | 3 | 21285247 | |
| Pubmed | A missense mutation in the type II hair keratin hHb3 is associated with monilethrix. | 1.10e-06 | 2 | 37 | 2 | 15744029 | |
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 9665406 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 9402962 | ||
| Pubmed | Sequences and differential expression of three novel human type-II hair keratins. | 3.30e-06 | 3 | 37 | 2 | 9084137 | |
| Pubmed | 6.60e-06 | 4 | 37 | 2 | 9457912 | ||
| Pubmed | 1.10e-05 | 5 | 37 | 2 | 12435728 | ||
| Pubmed | 5.78e-05 | 70 | 37 | 3 | 34255829 | ||
| Pubmed | Sequence and expression of murine type I hair keratins mHa2 and mHa3. | 9.94e-05 | 14 | 37 | 2 | 7514534 | |
| Pubmed | 1.15e-04 | 15 | 37 | 2 | 33722956 | ||
| Pubmed | Hague (Hag). A new mouse hair mutation with an unstable semidominant allele. | 1.31e-04 | 16 | 37 | 2 | 12399393 | |
| Pubmed | Mapping Extracellular Protein-Protein Interactions Using Extracellular Proximity Labeling (ePL). | 1.36e-04 | 247 | 37 | 4 | 39238192 | |
| Pubmed | 1.48e-04 | 96 | 37 | 3 | 23580065 | ||
| Pubmed | 1.48e-04 | 17 | 37 | 2 | 12747765 | ||
| Pubmed | 1.81e-04 | 266 | 37 | 4 | 19380743 | ||
| Pubmed | 1.86e-04 | 19 | 37 | 2 | 27234308 | ||
| Pubmed | ZFP628 Is a TAF4b-Interacting Transcription Factor Required for Mouse Spermiogenesis. | 2.28e-04 | 21 | 37 | 2 | 31932482 | |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | 3.36e-04 | 573 | 37 | 5 | 28330616 | |
| Pubmed | 3.60e-04 | 1285 | 37 | 7 | 35914814 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 3.61e-04 | 582 | 37 | 5 | 20467437 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | 6.20e-04 | 1005 | 37 | 6 | 19615732 | |
| Pubmed | 7.75e-04 | 1049 | 37 | 6 | 27880917 | ||
| Pubmed | 8.99e-04 | 407 | 37 | 4 | 12693553 | ||
| Pubmed | Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα. | 9.61e-04 | 182 | 37 | 3 | 32239614 | |
| Pubmed | 9.67e-04 | 43 | 37 | 2 | 20565774 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 1.02e-03 | 1105 | 37 | 6 | 35748872 | |
| Interaction | EXOC4 interactions | 1.94e-06 | 213 | 36 | 6 | int:EXOC4 | |
| Interaction | KRT36 interactions | 9.02e-06 | 74 | 36 | 4 | int:KRT36 | |
| Interaction | KRT19 interactions | 9.74e-06 | 282 | 36 | 6 | int:KRT19 | |
| Interaction | KRT25 interactions | 3.29e-05 | 35 | 36 | 3 | int:KRT25 | |
| Interaction | C3orf18 interactions | 5.15e-05 | 115 | 36 | 4 | int:C3orf18 | |
| Interaction | NDE1 interactions | 5.51e-05 | 117 | 36 | 4 | int:NDE1 | |
| Interaction | GRB2 interactions | 7.06e-05 | 806 | 36 | 8 | int:GRB2 | |
| Interaction | TCHP interactions | 8.55e-05 | 131 | 36 | 4 | int:TCHP | |
| Interaction | PCM1 interactions | 1.09e-04 | 434 | 36 | 6 | int:PCM1 | |
| Interaction | STAM2 interactions | 1.33e-04 | 147 | 36 | 4 | int:STAM2 | |
| Interaction | KRT39 interactions | 1.59e-04 | 59 | 36 | 3 | int:KRT39 | |
| Interaction | TRAK2 interactions | 1.84e-04 | 62 | 36 | 3 | int:TRAK2 | |
| Interaction | NUDCD1 interactions | 1.93e-04 | 63 | 36 | 3 | int:NUDCD1 | |
| Interaction | DNAH11 interactions | 2.02e-04 | 12 | 36 | 2 | int:DNAH11 | |
| Cytoband | 12q13 | 2.65e-05 | 71 | 37 | 3 | 12q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q21 | 3.98e-04 | 177 | 37 | 3 | chr15q21 | |
| GeneFamily | Keratins, type II | 7.55e-06 | 27 | 26 | 3 | 609 | |
| Coexpression | GSE360_DC_VS_MAC_L_MAJOR_UP | 8.79e-06 | 200 | 37 | 5 | M5181 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 182 | 37 | 4 | bc8d621be57f76d718d9b0f11e023b0f4dcb668d | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 1.57e-05 | 183 | 37 | 4 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | Control-Lymphoid-ILC_A|Lymphoid / Disease state, Lineage and Cell class | 1.64e-05 | 185 | 37 | 4 | 520795866d44def5be3910ce8e728045c716a24d | |
| ToppCell | COPD-Epithelial-ATII|COPD / Disease state, Lineage and Cell class | 1.75e-05 | 188 | 37 | 4 | eb6d79d733b53f64ca615bb777c64ed456866549 | |
| ToppCell | distal-Hematologic-Natural_Killer_T-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.06e-05 | 196 | 37 | 4 | 05d2a15ba702b07ef59c55891a06da02cdd15f7f | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nxph3|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.37e-05 | 67 | 37 | 3 | b80bdd122a0284611161c40ec7a9c893dc8de4de | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.80e-05 | 104 | 37 | 3 | a4ae3cae44aac8b6e0d14896f9acab44f0cc97c4 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.78e-04 | 132 | 37 | 3 | 48449e2e95804a26f204ac7ea763dee26cf794ab | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-04 | 133 | 37 | 3 | f7d0763b5eec2db33044d6850fd57462494038c1 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_D2|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.50e-04 | 148 | 37 | 3 | 99536d36c2ab5fac92765dac4fd8827a9368b181 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_D2|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.75e-04 | 153 | 37 | 3 | 5fb7d92cddc816c64071465e955ed0ea3bb45316 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_C|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.91e-04 | 156 | 37 | 3 | a1b9e7621b646d354c2ccd850ce6a4fa9ff8a026 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.02e-04 | 158 | 37 | 3 | 74aa4f75307575ac3b2b1aa9f727753692f88742 | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Biphasic-6|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 3.08e-04 | 159 | 37 | 3 | 85501c636cd04f15ba1be24df1ba7ac909633ce8 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.31e-04 | 163 | 37 | 3 | 466c8129852a5b16cd9fcc6b79e799abc21bb21a | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-ILC3|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.31e-04 | 163 | 37 | 3 | 00e791358a7eb6c3e95f87afe22153845012e4a1 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_NK-NK_CD56bright_CD16-|GI_small-bowel / Manually curated celltypes from each tissue | 3.37e-04 | 164 | 37 | 3 | 36e64e4f717dd59b352c20ff9742ca1e232342bb | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-04 | 165 | 37 | 3 | 7c771f22b58989572c939ed127e637ec28dc0dca | |
| ToppCell | control-Epithelial-Ionocyte|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.43e-04 | 165 | 37 | 3 | 5cfba9a46bd8ceeca74a6493057b4d38af6b06fe | |
| ToppCell | moderate-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.49e-04 | 166 | 37 | 3 | c3835b424c63bf11a4e2c47635dc3787fc4a637a | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.62e-04 | 168 | 37 | 3 | 94cded2e953c0970bf2f3dbe0ce46bd77a5ed8c7 | |
| ToppCell | control-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.62e-04 | 168 | 37 | 3 | 327b02f19f4a8607c033203824fdc60a1254331f | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.62e-04 | 168 | 37 | 3 | 6a233045638cb83dab64789b996b7598c325001e | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-ILC3|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.68e-04 | 169 | 37 | 3 | d4a0bd792bddfa34332d7dc432ce253f50d98c6f | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-ILC3|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.81e-04 | 171 | 37 | 3 | 6ab7f103cbdbd49ef687cbb8a42ddc5517af0f7f | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.88e-04 | 172 | 37 | 3 | e3a8891694343b6b01e80a200ae338d24797e417 | |
| ToppCell | Ionocyte-iono-2|World / Class top | 3.94e-04 | 173 | 37 | 3 | e5ec28ccc5e048fd98de4c876e5c53b866b66228 | |
| ToppCell | COPD-Lymphoid-ILC_A|Lymphoid / Disease state, Lineage and Cell class | 3.94e-04 | 173 | 37 | 3 | 4a0043b29f8ede5a74bdb38cbf2c70e12b25e130 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.94e-04 | 173 | 37 | 3 | ef8d720b99470fe1953661f6e66bc0366266bdb6 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 4.01e-04 | 174 | 37 | 3 | 110369f6b78de34a6d934b5b47cecd023347bc80 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.01e-04 | 174 | 37 | 3 | b7f5492ce8098f7eb0aef30ee558d00738d59d0e | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.01e-04 | 174 | 37 | 3 | 7ebf06076946729c1af25109df6066731097c3b1 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.01e-04 | 174 | 37 | 3 | e5f12831187140e84b9a49e93b2376b9fefb1aec | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.01e-04 | 174 | 37 | 3 | 90961e8839514985712b8b986aec3391bb249ba7 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.01e-04 | 174 | 37 | 3 | cafe4d6b5f08d8888e9db6e196c66df991c03e7b | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.01e-04 | 174 | 37 | 3 | 71730503be3d9c839c4c9e950145e2101d682a1c | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.01e-04 | 174 | 37 | 3 | c4b0987d9394f977fe6bc6a4214a6d8d73d0abcc | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.01e-04 | 174 | 37 | 3 | 58300d64d3b6fd9ba1b6c87ea83b2777eb6be2f4 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.01e-04 | 174 | 37 | 3 | ee8ac51fa0b426ad7b7453371bb79c8bf8c1d358 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 4.08e-04 | 175 | 37 | 3 | 2eca4c168dea2017ea0e383006e28abed22f32ec | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.08e-04 | 175 | 37 | 3 | 8fb8c4b9e2d9b7d737f59cd9bd3dc2bca5a8dfc4 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.15e-04 | 176 | 37 | 3 | bd5c85b3a4fb88ffe156599f6d224aa7664a513a | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-NK_T_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.15e-04 | 176 | 37 | 3 | dbc4f64cd39b229f2355ca1d0215cc7f6a767dce | |
| ToppCell | FF-Differ-KC|World / shred by cell class for mouse tongue | 4.36e-04 | 179 | 37 | 3 | 1526a130565a97c291a25a7a988089bffc1515c1 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-T_cells|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.36e-04 | 179 | 37 | 3 | e717c0079b788a3703c0a450922bd5a2bdc322a0 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.36e-04 | 179 | 37 | 3 | dd3cf8fd10dc257d933a7f45860dc2e244c158b7 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_NK-T_NK-ILC_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.36e-04 | 179 | 37 | 3 | bc95c3e7edc5fc6fc913b09f087d221df64c6f48 | |
| ToppCell | NS-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.36e-04 | 179 | 37 | 3 | 65a96bee7bc28f5bfc20f0fd92bcc0ab2eb5e06c | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.43e-04 | 180 | 37 | 3 | c72f15763ba707189e29c85db533557f01c7fdb1 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.43e-04 | 180 | 37 | 3 | ca7c316027e31559103b2cab1a2c0de993e42e95 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-T_cells|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.43e-04 | 180 | 37 | 3 | eb26ba86fba26899e54c448afc25382ddc853013 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_NK-T_NK-ILC_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.43e-04 | 180 | 37 | 3 | a999a6d219a8e58a8b63802ddf8c95ffaab9cfa0 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_A|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.43e-04 | 180 | 37 | 3 | 023c83f0c9d0280983c6fd28ecf04bfa6b1b89e2 | |
| ToppCell | critical-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.50e-04 | 181 | 37 | 3 | f0d81ae74d3f32979624a94b2ef93774831a7970 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-NK_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.57e-04 | 182 | 37 | 3 | feda21c92d30848de70c8b404eaabbca3f5e894d | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.57e-04 | 182 | 37 | 3 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-T_&_ILC-ILCP|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.57e-04 | 182 | 37 | 3 | 6bd48c5d60a259719f65cacee4b8135247e78fa9 | |
| ToppCell | T_cells-Resident_memory_CD8+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 4.57e-04 | 182 | 37 | 3 | 111d434b89902ec11fb07f41b8ee1a98f3991b61 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR-_ILC3|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.65e-04 | 183 | 37 | 3 | 2c0b1265af2bca2c378ff7104bce337c98053b5e | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.65e-04 | 183 | 37 | 3 | 351d575339038bd4a66f408da518c567444208e8 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.65e-04 | 183 | 37 | 3 | d4a558bc0b8e11be195a7da1468ab38eb477117d | |
| ToppCell | wk_08-11-Hematologic_Lymphocytic-T_&_ILC-ILCP|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.65e-04 | 183 | 37 | 3 | 797eb968c57e48db33ff8e2236ee22e9425c4676 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Pdyn_(MGE-derived_cortical_interneurons--Martinotti_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.78e-04 | 39 | 37 | 2 | 66fe368f1dfe665c661cf9baf854d12eb28c25b8 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Pdyn_(MGE-derived_cortical_interneurons--Martinotti_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.78e-04 | 39 | 37 | 2 | d5b0bcdfb27c881049178079c48deb587a0b2fda | |
| ToppCell | Control-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 4.79e-04 | 185 | 37 | 3 | 6814b3c94c7558443c038a227b5c8563d2cfeac4 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-04 | 185 | 37 | 3 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | IPF-Epithelial-ATII|IPF / Disease state, Lineage and Cell class | 4.79e-04 | 185 | 37 | 3 | 563b4e6d92bb5d77a3829556116a8e99aebac615 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.79e-04 | 185 | 37 | 3 | e1fd66f4295056807aa29c0e4ce6b1a79cc8dfcf | |
| ToppCell | IIH-NK|IIH / Condition, Cell_class and T cell subcluster | 4.87e-04 | 186 | 37 | 3 | cab1249b849013cf0334f25ee8d840f0521f4eb8 | |
| ToppCell | IIH-NK-|IIH / Condition, Cell_class and T cell subcluster | 4.87e-04 | 186 | 37 | 3 | 2c90b45c8ccfd86bbf6840dba7f0d7f08b5ea914 | |
| ToppCell | IPF-Epithelial-ATII|World / Disease state, Lineage and Cell class | 4.87e-04 | 186 | 37 | 3 | 6a4ff2da0af0f5e590d9f9daa5b5e9ac8c868947 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.87e-04 | 186 | 37 | 3 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | Control-Epithelial-ATII|World / Disease state, Lineage and Cell class | 4.87e-04 | 186 | 37 | 3 | f4b6e401e19a71beddc73d8a1e08359f7c4025cf | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-ILC_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.95e-04 | 187 | 37 | 3 | f31d865ce2a21bdf64dbe29ee3e4505ab482604a | |
| ToppCell | facs-Bladder-nan-24m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-04 | 187 | 37 | 3 | 2c145e9d11424939dd99012a8cedf5d998b966e9 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.10e-04 | 189 | 37 | 3 | 1893765b1e3b306f1e133101c28403070a70c3c8 | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NKT|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.10e-04 | 189 | 37 | 3 | 24519fa45e7d1c2fb397e9ffe00ecb7f7d4cefd8 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.10e-04 | 189 | 37 | 3 | 5c85656f555d91ecc9540faa67717694a4aef92f | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid_mast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.10e-04 | 189 | 37 | 3 | 96566f84c796d5b2e31f64090555f2b258f0c9f2 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid_mast-Myeloid_Mast/Baso|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.10e-04 | 189 | 37 | 3 | 19b639bc6b35fe1d1079f60c8138aa946a95f3bf | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.10e-04 | 189 | 37 | 3 | b59cc66f7bb9b72895b775fbcf1ec1dc08610969 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.10e-04 | 189 | 37 | 3 | 723c57f278919e8251d56b3d19411f9088319450 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK-T_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.10e-04 | 189 | 37 | 3 | 960374f5fb278659500a7c948c3068a95dd62eb0 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR-_ILC3|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.18e-04 | 190 | 37 | 3 | af39d2a46d9502cec69a69b7e8ffef78fc8311c3 | |
| ToppCell | metastatic_Brain-T/NK_cells-NK|metastatic_Brain / Location, Cell class and cell subclass | 5.18e-04 | 190 | 37 | 3 | 50e937ba0600e1ac6215f056bb545dc1e8b28a76 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.18e-04 | 190 | 37 | 3 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.18e-04 | 190 | 37 | 3 | ed100e271aac82806f59e0c613ccda63f59100c1 | |
| ToppCell | Control-Epithelial-ATII|Control / Disease state, Lineage and Cell class | 5.18e-04 | 190 | 37 | 3 | d50902a3abcc18aafa36d83cc2c6e07d7f7cb197 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.18e-04 | 190 | 37 | 3 | ce049630ed69d31f00acbc1b5b0896efc592121f | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-filiform|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-04 | 190 | 37 | 3 | 251e3a33041023bfc4b547c7eb68cfb8f421636f | |
| ToppCell | (4)_Endothelial_cells-(40)_EC-arterial|(4)_Endothelial_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 5.18e-04 | 190 | 37 | 3 | ff774faf3f12759d11e50ed7d189288bb79e22e1 | |
| ToppCell | P07|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.18e-04 | 190 | 37 | 3 | 38a613a9bca0ba040c3ada00286d1ce6f83ab23a | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-04 | 190 | 37 | 3 | aaf5f1c1ff7b1454f4e5dacfeb48e1c3627e3372 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-04 | 190 | 37 | 3 | a20123d5c6cb8c2f0dfd99bbfdb571a73c36234d | |
| ToppCell | PSB-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.26e-04 | 191 | 37 | 3 | 8f4637e801554e2343b974fe7794f01dd2151418 | |
| ToppCell | facs-Lung-3m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.26e-04 | 191 | 37 | 3 | f98fc372e579ce69409afbbe0f83c03c7ea62632 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.26e-04 | 191 | 37 | 3 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.26e-04 | 191 | 37 | 3 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | facs-Lung-3m-Epithelial-alveolar_epithelial-type_II_pneumocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.26e-04 | 191 | 37 | 3 | 210589095a3f5d5117174caf6ec110b502f27030 | |
| ToppCell | Control-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 5.34e-04 | 192 | 37 | 3 | 1bfd022d5b87cf8a5d5069f559339a553a52a0a2 | |
| Drug | tebuquine | 2.57e-06 | 2 | 37 | 2 | CID000071991 | |
| Drug | 3,5-di-O-galloylquinic acid | 2.57e-06 | 2 | 37 | 2 | CID000460896 | |
| Drug | melicopicine | 2.57e-06 | 2 | 37 | 2 | CID000101253 | |
| Drug | AC1L1BIT | 2.70e-06 | 60 | 37 | 4 | CID000001457 | |
| Drug | ATBI | 3.17e-06 | 18 | 37 | 3 | CID000505862 | |
| Drug | 4-aminoquinoline | 5.15e-06 | 21 | 37 | 3 | CID000068476 | |
| Drug | pyriproxyfen | 6.84e-06 | 23 | 37 | 3 | CID000091753 | |
| Drug | sulfonamide-3 | 7.70e-06 | 3 | 37 | 2 | CID009847197 | |
| Drug | Ethynodiol diacetate [297-76-7]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 1.38e-05 | 191 | 37 | 5 | 6479_UP | |
| Drug | AC1L9MJT | 1.42e-05 | 192 | 37 | 5 | CID000448959 | |
| Drug | lactucin | 1.54e-05 | 4 | 37 | 2 | CID000442266 | |
| Drug | Lactupicrin | 1.54e-05 | 4 | 37 | 2 | CID000174880 | |
| Drug | Tiaprofenic acid [33005-95-7]; Up 200; 15.4uM; HL60; HT_HG-U133A | 1.64e-05 | 198 | 37 | 5 | 2492_UP | |
| Drug | dansyl chloride | 2.80e-05 | 108 | 37 | 4 | CID000011801 | |
| Drug | dictamnine | 3.84e-05 | 6 | 37 | 2 | CID000068085 | |
| Drug | skimmianine | 3.84e-05 | 6 | 37 | 2 | CID000006760 | |
| Drug | arborinine | 3.84e-05 | 6 | 37 | 2 | CID005281832 | |
| Drug | teleocidin B | 4.67e-05 | 123 | 37 | 4 | CID000072425 | |
| Drug | TGQA | 5.37e-05 | 7 | 37 | 2 | CID000127406 | |
| Drug | sulfur mustard | 5.79e-05 | 130 | 37 | 4 | CID000010461 | |
| Drug | homocysteine thiolactone | 5.97e-05 | 131 | 37 | 4 | CID000107712 | |
| Drug | desethylchloroquine | 7.15e-05 | 8 | 37 | 2 | CID000095478 | |
| Drug | AC1NS0KV | 8.85e-05 | 145 | 37 | 4 | CID005326475 | |
| Drug | bisdesethylchloroquine | 9.18e-05 | 9 | 37 | 2 | CID000122672 | |
| Drug | 1-2q | 9.95e-05 | 289 | 37 | 5 | CID000011820 | |
| Drug | 8-amino-2-methylquinoline | 1.40e-04 | 11 | 37 | 2 | CID000140457 | |
| Drug | al-Badry | 1.46e-04 | 165 | 37 | 4 | CID000004545 | |
| Drug | salsalate | 1.68e-04 | 66 | 37 | 3 | CID000005161 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.95e-04 | 178 | 37 | 4 | 6276_DN | |
| Drug | trioxane | 1.98e-04 | 13 | 37 | 2 | CID000008081 | |
| Drug | arteether | 1.98e-04 | 13 | 37 | 2 | CID000072416 | |
| Drug | Mal.4 | 2.18e-04 | 72 | 37 | 3 | CID000122821 | |
| Drug | retinoic acid; Up 200; 1uM; MCF7; HT_HG-U133A | 2.26e-04 | 185 | 37 | 4 | 6931_UP | |
| Drug | Hb 7 | 2.31e-04 | 14 | 37 | 2 | CID000128180 | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 2.50e-04 | 190 | 37 | 4 | 5586_DN | |
| Drug | Methionine sulfoximine (L) [15985-39-4]; Up 200; 22.2uM; MCF7; HT_HG-U133A | 2.60e-04 | 192 | 37 | 4 | 4151_UP | |
| Drug | Enilconazole [35554-44-0]; Down 200; 13.4uM; HL60; HT_HG-U133A | 2.66e-04 | 193 | 37 | 4 | 3139_DN | |
| Drug | STOCK1N-28457; Down 200; 20uM; MCF7; HT_HG-U133A | 2.66e-04 | 193 | 37 | 4 | 6869_DN | |
| Drug | geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A | 2.66e-04 | 193 | 37 | 4 | 1653_DN | |
| Drug | CP-9 | 2.66e-04 | 15 | 37 | 2 | CID000452634 | |
| Drug | CP-863187 [668981-07-5]; Down 200; 10uM; PC3; HT_HG-U133A | 2.71e-04 | 194 | 37 | 4 | 7558_DN | |
| Drug | Meclozine dihydrochloride [1104-22-9]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 2.71e-04 | 194 | 37 | 4 | 3285_UP | |
| Drug | valinomycin; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.76e-04 | 195 | 37 | 4 | 5911_DN | |
| Drug | Chlorogenic acid [327-97-9]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 2.76e-04 | 195 | 37 | 4 | 3282_UP | |
| Drug | PF-00562151-00 [351320-12-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 2.76e-04 | 195 | 37 | 4 | 6868_DN | |
| Drug | ST021200; Up 200; 10uM; PC3; HT_HG-U133A | 2.76e-04 | 195 | 37 | 4 | 7559_UP | |
| Drug | SR-95639A [115767-94-7]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.76e-04 | 195 | 37 | 4 | 3272_UP | |
| Drug | Nitrendipine [39562-70-4]; Up 200; 11uM; MCF7; HT_HG-U133A | 2.76e-04 | 195 | 37 | 4 | 5405_UP | |
| Drug | 6-Furfurylaminopurine [525-79-1]; Down 200; 18.6uM; HL60; HT_HG-U133A | 2.82e-04 | 196 | 37 | 4 | 2511_DN | |
| Drug | Epicatechin-(-) [154-23-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 2.82e-04 | 196 | 37 | 4 | 2815_UP | |
| Drug | Spiramycin [8025-81-8]; Up 200; 4.8uM; PC3; HT_HG-U133A | 2.82e-04 | 196 | 37 | 4 | 4319_UP | |
| Drug | Aminophylline [317-34-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 2.82e-04 | 196 | 37 | 4 | 3374_DN | |
| Drug | Syrosingopine [84-36-6]; Down 200; 6uM; PC3; HT_HG-U133A | 2.82e-04 | 196 | 37 | 4 | 5733_DN | |
| Drug | Tubocurarine chloride pentahydrate (+) [6989-98-6]; Down 200; 5.2uM; MCF7; HT_HG-U133A | 2.87e-04 | 197 | 37 | 4 | 5449_DN | |
| Drug | estradiol; Up 200; 0.01uM; PC3; HT_HG-U133A | 2.87e-04 | 197 | 37 | 4 | 5960_UP | |
| Drug | Bupivacaine hydrochloride [18010-40-7]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 2.87e-04 | 197 | 37 | 4 | 5537_UP | |
| Drug | Chlorprothixene hydrochloride [6469-93-8]; Up 200; 11.4uM; HL60; HT_HG-U133A | 2.93e-04 | 198 | 37 | 4 | 1272_UP | |
| Drug | Graveoline [485-61-0]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 2.93e-04 | 198 | 37 | 4 | 6034_UP | |
| Drug | GBR 12909 dihydrochloride [67469-78-7]; Down 200; 7.6uM; HL60; HG-U133A | 2.93e-04 | 198 | 37 | 4 | 1625_DN | |
| Drug | Clioquinol [130-26-7]; Down 200; 13uM; MCF7; HT_HG-U133A | 2.98e-04 | 199 | 37 | 4 | 5623_DN | |
| Drug | Trichlorfon [52-68-6]; Up 200; 15.6uM; PC3; HT_HG-U133A | 2.98e-04 | 199 | 37 | 4 | 7287_UP | |
| Drug | Zimelidine dihydrochloride monohydrate [61129-30-4]; Up 200; 9.8uM; HL60; HG-U133A | 2.98e-04 | 199 | 37 | 4 | 2012_UP | |
| Drug | Amrinone [60719-84-8]; Down 200; 21.4uM; MCF7; HT_HG-U133A | 3.04e-04 | 200 | 37 | 4 | 3465_DN | |
| Drug | CQ-S | 3.44e-04 | 17 | 37 | 2 | CID000072462 | |
| Drug | sulfadoxine-pyrimethamine | 3.87e-04 | 18 | 37 | 2 | CID000065404 | |
| Disease | Beaded hair | 1.81e-09 | 3 | 37 | 3 | cv:C0546966 | |
| Disease | MONILETHRIX | 1.81e-09 | 3 | 37 | 3 | 158000 | |
| Disease | monilethrix (is_implicated_in) | 1.81e-09 | 3 | 37 | 3 | DOID:0050472 (is_implicated_in) | |
| Disease | Monilethrix | 7.25e-09 | 4 | 37 | 3 | C0546966 | |
| Disease | hair disease (is_implicated_in) | 1.53e-06 | 2 | 37 | 2 | DOID:421 (is_implicated_in) | |
| Disease | energy expenditure | 5.26e-04 | 27 | 37 | 2 | EFO_0005109 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SELLEDMMIEMRRCY | 496 | Q8NAT2 | |
| VRIEEMERDLDMYSR | 696 | Q6XZF7 | |
| MERDLDMYSRAQEEL | 701 | Q6XZF7 | |
| TILRYCTDDMLQREM | 156 | Q7L7V1 | |
| DRPEEELMQYEVMCL | 341 | Q96MI9 | |
| EMYEVRIAAVEALCM | 386 | Q96HW7 | |
| ELRAEMEEMRDSYLE | 356 | Q9Y4B5 | |
| ALYNKEMECLRMTDE | 1276 | Q9NS87 | |
| EMECLRMTDEVERTQ | 1281 | Q9NS87 | |
| YEERERTSQEMEMLR | 1316 | Q9NS87 | |
| LTRVLEEMRCQYEAM | 261 | Q14532 | |
| EEMRCQYEAMVEANR | 266 | Q14532 | |
| DMACLIREYQEVMNS | 381 | O43790 | |
| DLQDDMRRCQIIRDM | 226 | Q7L5Y1 | |
| LRMAADDVEEYMIER | 81 | Q9BUL8 | |
| LDTCLYVMDRAQMDL | 236 | P00488 | |
| EDLMKELYQRCERMR | 246 | Q9UJY5 | |
| MMDLRRYPLDEQNCT | 161 | P47870 | |
| SLCSIEEEHRMVYEM | 376 | Q2PPJ7 | |
| MAAREQQVYCEEMRE | 381 | O95140 | |
| YDEMMELLRCHREKI | 626 | Q9UFH2 | |
| QDEMRLMEEELRDYQ | 1011 | Q0VF96 | |
| YVLREDRRMCKDEDE | 2236 | P35555 | |
| VLLQRCMMDTDDEVR | 511 | Q9UBF2 | |
| RVLMEDDDLYSCMVE | 206 | Q14CZ8 | |
| REEQDIEIMMEGCEY | 166 | Q9NV70 | |
| DMACLIREYQEVMNS | 386 | P78385 | |
| CYIVIDIMLDMAERE | 1091 | Q15262 | |
| CLRDLIFCMEQEREM | 836 | Q92750 | |
| SRENDCLQEELRMME | 1256 | Q8N4C6 | |
| CLQEELRMMETRYDE | 1261 | Q8N4C6 | |
| LRMMETRYDEALENN | 1266 | Q8N4C6 | |
| TICYLDMLMTSEERR | 236 | Q9H7B4 | |
| LRELEDKYAECMEML | 326 | Q9UPV9 | |
| MERVVEQMCITQYER | 206 | P04156 | |
| EDYNREMERDMDRDV | 1276 | P49750 | |
| ERPDNCSEEMYRLML | 971 | P07949 | |
| DVVDSCSMLYRLQME | 291 | Q5R3I4 | |
| SQMTRVLDILEDYCM | 506 | O60264 | |
| SPRDEDMLCYLMNLE | 211 | Q9H489 | |
| IMDARRMQDYQDSCI | 201 | P40818 | |
| MSAEEMVQIRLEDRC | 1 | Q9P2K6 | |
| DMACLIREYQEVMNS | 381 | Q14533 |